Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trial.

@article{Gingnell2016CombiningEA,
  title={Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trial.},
  author={Malin Gingnell and Andreas Frick and Jonas Engman and Iman Alaie and Johannes Bj{\"o}rkstrand and V. P. de Faria and Per Carlbring and Gerhard Andersson and Margareta Reis and Elna-Marie Larsson and Kurt G I Wahlstedt and Mats Fredrikson and Tomas Furmark},
  journal={The British journal of psychiatry : the journal of mental science},
  year={2016},
  volume={209 3},
  pages={
          229-35
        }
}
BACKGROUND Selective serotonin reuptake inhibitors (SSRIs) and cognitive-behavioural therapy (CBT) are often used concomitantly to treat social anxiety disorder (SAD), but few studies have examined the effect of this combination. AIMS To evaluate whether adding escitalopram to internet-delivered CBT (ICBT) improves clinical outcome and alters brain reactivity and connectivity in SAD. METHOD Double-blind, randomised, placebo-controlled neuroimaging trial of ICBT combined either with… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 13 times over the past 90 days. VIEW TWEETS